triphenylphosphine has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Huang, Q; Huang, Y; Li, P; Qin, L; Shi, W; Wang, H; Wen, H; Xie, J; Zhang, F; Zhou, Y | 1 |
1 other study(ies) available for triphenylphosphine and paclitaxel
Article | Year |
---|---|
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Drug Resistance, Neoplasm; Endocytosis; Female; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Lung Neoplasms; Lysosomes; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Micelles; Mitochondria; Mitochondrial Membranes; Nanoparticles; Organophosphorus Compounds; Paclitaxel; Poloxamer; Proton Magnetic Resonance Spectroscopy; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |